11-tetradecenyl acetate is an organic compound, specifically an **insect pheromone**. It plays a crucial role in the communication and behavior of certain insect species, particularly **moths**, and is therefore of significant importance for various research fields.
**Here's why 11-tetradecenyl acetate is important for research:**
* **Pesticide Development:** Understanding how insects use pheromones to communicate allows scientists to develop **pheromone-based pesticides**. These pesticides can be more targeted and environmentally friendly than traditional insecticides because they only affect the specific insect species being targeted.
* **Pest Control:** Pheromones can be used to monitor insect populations, predict outbreaks, and develop effective control strategies for pest species. This is especially useful for agricultural and forestry applications.
* **Behavioral Ecology:** Studying the role of pheromones in insect behavior provides valuable insights into their mating rituals, social structures, and interactions with the environment. This knowledge contributes to a deeper understanding of insect ecology and evolution.
* **Chemical Communication:** 11-tetradecenyl acetate is a valuable model compound for studying the chemical mechanisms of pheromone reception and transduction. This research helps us understand how insects perceive and respond to chemical signals in their environment.
**In summary, 11-tetradecenyl acetate is an important research tool because it provides valuable insights into insect communication, behavior, and ecology. This knowledge has significant implications for the development of novel pest control strategies, the understanding of biodiversity, and the development of new technologies in the field of chemical communication.**
11-tetradecenyl acetate: RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 5367650 |
| CHEMBL ID | 3182789 |
| CHEBI ID | 179817 |
| SCHEMBL ID | 434571 |
| MeSH ID | M0058780 |
| Synonym |
|---|
| 11e-tetradecenyl acetate |
| 26532-95-6 |
| CHEBI:179817 |
| [(e)-tetradec-11-enyl] acetate |
| trans-11-tetradecen-1-yl acetate |
| trans-11-tetradecenyl acetate |
| (11e)-11-tetradecenyl acetate |
| 11-tetradecen-1-ol acetate |
| trans-11-tetradecenyl acetate, ~97% |
| NCGC00164396-01 |
| (e)-11-tetradecenyl acetate |
| einecs 251-401-4 |
| (e)-11-tetradecen-1-ol acetate |
| epa pesticide chemical code 129019 |
| 11-tetradecen-1-ol, acetate, (11e)- |
| 11-tetradecen-1-ol, acetate, (e)- |
| epa pesticide chemical code 128980 |
| (e)-tetradec-11-enyl acetate |
| ai3-35943 |
| 11-tetradecenyl acetate |
| NCGC00164396-02 |
| grape berry moth pheromone |
| 11-tetradecen-1-ol, acetate |
| LMFA07010285 |
| NCGC00254953-01 |
| cas-33189-72-9 |
| dtxcid9015286 |
| dtxsid1035286 , |
| tox21_301051 |
| unii-uxj691z784 |
| 11-tetradecenyl acetate, (11e)- |
| 33189-72-9 |
| uxj691z784 , |
| 11-tetradecen-1-ol, 1-acetate, (11e)- |
| SCHEMBL434571 |
| trans-11-tetradecenol acetate |
| tetradecen-1-ol acetate, (e)-11- |
| YJINQJFQLQIYHX-UHFFFAOYSA-N |
| trans-tetradec-11-en-1-yl acetate |
| (11e)-tetradecen-1-yl acetate |
| (11e)-tetradec-11-en-1-yl acetate |
| trans-11-tetradecenylacetate |
| (11e)-11-tetradecenyl acetate # |
| YJINQJFQLQIYHX-SNAWJCMRSA-N |
| CHEMBL3182789 |
| e-11-tetradecenyl acetate |
| mfcd00064462 |
| E75959 |
| Q27291316 |
| (e)-11-tetradecen-1-yl acetate 100 microg/ml in acetonitrile |
| BS-49280 |
| CS-0160320 |
| Excerpt | Relevance | Reference |
|---|---|---|
| "Medflies topically dosed with moth pheromone (E)-11-tetradecenyl acetate showed a no observed effect level (NOEL) of ~10 µg fly(-1) , with increasing toxicity from 30 to 100 µg fly(-1) ." | ( Mobile mating disruption of light-brown apple moths using pheromone-treated sterile Mediterranean fruit flies. Jang, EB; Lacey, I; Mitchell, VJ; Suckling, DM; Twidle, A; Wallace, AR; Woods, B, 2011) | 0.62 |
| Class | Description |
|---|---|
| carboxylic ester | An ester of a carboxylic acid, R(1)C(=O)OR(2), where R(1) = H or organyl and R(2) = organyl. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] | |
| Pathway | Proteins | Compounds |
|---|---|---|
| Spodoptera littoralis pheromone biosynthesis | 0 | 32 |
| Protein | Taxonomy | Measurement | Average (µ) | Min (ref.) | Avg (ref.) | Max (ref.) | Bioassay(s) |
|---|---|---|---|---|---|---|---|
| nuclear receptor subfamily 1, group I, member 3 | Homo sapiens (human) | Potency | 54.4827 | 0.0010 | 22.6508 | 76.6163 | AID1224838 |
| retinoid X nuclear receptor alpha | Homo sapiens (human) | Potency | 24.5412 | 0.0008 | 17.5051 | 59.3239 | AID1159531 |
| peroxisome proliferator activated receptor gamma | Homo sapiens (human) | Potency | 30.8956 | 0.0010 | 19.4141 | 70.9645 | AID743191 |
| thyroid hormone receptor beta isoform 2 | Rattus norvegicus (Norway rat) | Potency | 38.5708 | 0.0003 | 23.4451 | 159.6830 | AID743066 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] | |||||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (6.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 1 (6.25) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (19.74) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 17 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||